Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 451–454 of 454 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00530192	Molecular Profiling Protocol (SCRI-CA-001)	completed	Early Phase 1	86	Scottsdale HealthcareOTHER	1	Jul 10, 2009	clinicaltrials
NCT00221169	Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer	completed	Early Phase 1	31	Toronto Sunnybrook Regional Cancer CentreOTHER	1	Feb 5, 2009	clinicaltrials